Home › Membranous Glomerulonephritis › North Carolina
Membranous Glomerulonephritis clinical trials in North Carolina
3 studies for Membranous Glomerulonephritis are looking for participants at sites in North Carolina.
Cities in North Carolina
Belimumab With Rituximab for Primary Membranous Nephropathy
- University of North Carolina School of Medicine: Division of Nephrology and Hypertension, Kidney Center, Chapel Hill
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT03949855NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.